Unitary biochip providing sample-in to results-out processing and methods of manufacture

Inventors

Selden, Richard F.Tan, Eugene

Assignees

Ande Corp

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-11612893-B2

Patent

Publication Date

2023-03-28

Expiration Date


Abstract

A biochip for the integration of all steps in a complex process from the insertion of a sample to the generation of a result, performed without operator intervention includes microfluidic and macrofluidic features that are acted on by instrument subsystems in a series of scripted processing steps. Methods for fabricating these complex biochips of high feature density by injection molding are also provided.

Core Innovation

The invention provides an integrated, unitary, stationary biochip for conducting a multiplexed PCR analysis of at least two nucleic acids in an instrument that includes a process controller and a pneumatic subsystem. The biochip uses a pneumatic subassembly with a pneumatic plate aligned with a fluidics assembly, where drive lines contain only air and pressure is delivered to top ends of preloaded elution reagent storage chambers. The delivered pressure causes first and second foils to burst, and scripted controls from the process controller release contents from the preloaded reagent storage chambers.

The biochip includes a macrofluidic block with an inlet for receiving at least two nucleic acids and at least one preloaded elution reagent storage chamber that has a top end and a bottom end, with a first foil seal bonded to the bottom end and a second foil seal bonded to the top end. A fluidics subassembly is provided with at least one reconstitution chamber preloaded with lyophilized multiplexed PCR reagent and positioned in fluid communication with the elution reagent storage chamber, and at least one thermal cycling chamber. A primary flow path places the reconstitution chamber in fluidic communication with the thermal cycling chamber so that eluted nucleic acids are followed by reconstitution of the lyophilized multiplexed PCR reagent to generate PCR mix solution that travels along the flow path to the thermal cycling chamber.

In a unitary implementation, at least one combination reconstitution/thermal cycling chamber is preloaded with lyophilized multiplexed PCR reagent and positioned in fluid communication with the elution reagent storage chamber, allowing direct amplification after elution and reconstitution. A higher multiplexing architecture provides at least five preloaded elution reagent storage chambers, at least five reconstitution chambers, at least five thermal cycling chambers, and at least five primary flow paths to deliver PCR mix solutions to corresponding thermal cycling chambers.

Claims Coverage

The provided material includes three independent claims. Across these claims, the core inventive coverage centers on the pneumatic foil-burst release interface with scripted pressure control, the macrofluidic preloaded elution reagent chambers, and the microfluidic reconstitution and thermal cycling flow path arrangements for PCR mix generation and amplification.

Pneumatic foil-burst release via air-only pneumatic plate and scripted controls

A pneumatic subassembly with a pneumatic plate comprising one or a plurality of drive lines containing only air, aligned with a fluidics assembly via through holes, configured to receive pressure from an instrument and deliver it to top ends of preloaded elution reagent storage chambers, thereby causing foils to burst and releasing contents under scripted controls from a process controller.

Macrofluidic preloaded elution reagent chambers for nucleic acid inlet and foil-sealed release

A macrofluidic block comprising at least one preloaded elution reagent storage chamber with a top end and a bottom end, having a first foil seal bonded to the bottom end and a second foil seal bonded to the top end, and an inlet for receiving at least two nucleic acids.

Elution followed by reconstitution of lyophilized multiplexed PCR reagent and PCR mix routing to thermal cycling

A fluidics subassembly comprising at least one reconstitution chamber preloaded with lyophilized multiplexed PCR reagent positioned in fluid communication with the elution reagent storage chamber, at least one thermal cycling chamber, and a primary flow path in fluidic communication with the reconstitution chamber and the thermal cycling chamber such that pressure-delivered foil bursting results in elution of the nucleic acids followed by reconstitution to generate a PCR mix solution that travels along the flow path to the thermal cycling chamber.

Direct amplification in a combination reconstitution/thermal cycling chamber preloaded with lyophilized multiplexed PCR reagent

A unitary biochip where the fluidics subassembly includes at least one combination reconstitution/thermal cycling chamber preloaded with lyophilized multiplexed PCR reagent positioned in fluid communication with the elution reagent storage chamber, and a primary flow path in fluidic communication with the combination reconstitution/thermal cycling chamber such that foil-burst elution followed by reconstitution produces PCR mix solution followed by direct amplification in the combination reconstitution/thermal cycling chamber.

Five-solution multiplexed PCR with at least five elution chambers, reconstitution chambers, thermal cycling chambers, and primary flow paths

A unitary biochip for at least five nucleic acid solutions where the macrofluidic block includes at least five preloaded elution reagent storage chambers, the fluidics subassembly includes at least five reconstitution chambers each preloaded with lyophilized multiplexed PCR reagent and positioned in fluid communication with the elution reagent storage chambers, at least five thermal cycling chambers, and at least five primary flow paths each in fluid communication with the reconstitution chambers and the thermal cycling chambers such that pressure causes foil bursting, elution of nucleic acids in the at least five solutions, reconstitution of lyophilized multiplexed PCR reagent to generate PCR mix solutions, and delivery of PCR mix along the flow paths to the thermal cycling chambers.

The independent claims collectively require an instrument-driven pneumatic interface that bursts foil-sealed, preloaded elution reagent storage chambers under scripted controls, followed by microfluidic elution of nucleic acids and reconstitution of lyophilized multiplexed PCR reagent to generate PCR mix solution. They further require routing of the PCR mix to thermal cycling chambers, either via separate reconstitution and thermal cycling chambers, via direct amplification in a combination reconstitution/thermal cycling chamber, or via a higher multiplexing architecture providing at least five parallel sets of elution, reconstitution, and thermal cycling chambers and flow paths.

Stated Advantages

Supports sample-in to results-out analyses in a single instrument under scripted pneumatic, thermal, high-voltage, and optical control.

Enables high sample-processing and scripted-step complexity without operator intervention.

Uses unitary plastic construction and dense features including microfluidic and macrofluidic plates and foil-based reagent storage and release.

Provides fabrication and throughput advantages and cost and contamination reduction rationale.

Documentation includes multiple experimental examples demonstrating automation scripts and generation of STR profiles and electropherograms.

Documented Applications

Buccal swab STR automation.

Injection-molded 5-sample/16-plex PCR.

Sample splitting and dilution without quantitation.

Generation of STR profiles and electropherograms.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.